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Abstract
Central Asian Strain 1 (CAS1) is the prevalent Mycobacterium tuberculosis genogroup in South Asia. CAS1 strains carry
deletions in RD149 and RD152 regions. Significance of these deletions is as yet unknown. We compared CAS1 strains with
RD149 and concurrent RD149-RD152 deletions with CAS1 strains without deletions and with the laboratory reference strain,
M. tuberculosis H37Rv for growth and for induction of TNFa, IL6, CCL2 and IL10 in THP-1 cells. Growth of CAS1 strains with
deletions was slower in broth (RD149; p=0.024 and RD149-RD152; p=0.025) than that of strains without deletions. CAS1
strains with RD149 deletion strains further showed reduced intracellular growth (p=0.013) in THP-1 cells as compared with
strains without deletions, and also as compared with H37Rv (p=0.007) and with CAS1 RD149-RD152 deletion strains
(p=0.029). All CAS1 strains induced higher levels of TNFa and IL10 secretion in THP-1 cells than H37Rv. Additionally, CAS1
strains with RD149 deletions induced more TNFa secretion than those without deletions (p=0.013). CAS1 RD149 deletion
strains from extrapulmonary sources showed more rapid growth and induced lower levels of TNFa and IL6 secretion in THP-
1 cells than isolates from pulmonary sources. This data suggests that presence of RD149 reduces growth and increases the
induction of TNFa in host cells by CAS1 strains. Differences observed for extrapulmonary strains may indicate an adaptation
which increases potential for dissemination and tropism outside the lung. Overall, we hypothesise that RD149 deletions
generate genetic diversity within strains and impact interactions of CAS1 strains with host cells with important clinical
consequences.
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Introduction
Molecular epidemiological studies have suggested an associa-
tion between Mycobacterium tuberculosis strains and geographical
locations [1]. Predominant M. tuberculosis clades from the Indian
subcontinent include Central Asian strains (CAS) defined by
absence of spacers 4–7 and 23–34 [2,3]. Within the CAS strains,
CAS1_DEHLI (ST26) has been identified as being the most
widespread (39%) in Pakistan [4]. Reasons underlying successful
transmission of CAS genogroup strains in South Asia are
unknown. Large sequence polymorphisms (LSPs) or regions of
difference (RD) are identified as deletions or large sequence
polymorphisms in M. tuberculosis strains.
Amongst M. tuberculosis isolates from Pakistan, deletions in
RD149 are reported in 39.8% and concurrent RD149 and RD152
in 18.8% of CAS1 strains [5]. The impact of RD149 and RD152
deletions on M. tuberculosis biology is as yet unclear. RD149 region
is known to consist of probable phage proteins (Rv1572c-Rv1585c),
although the role of phage proteins has not been defined. RD152
region also consists of putative transposases (Rv1756c, Rv1764)
along with virulence factor, plcD (Rv1755c) [6,7]. Both RD149 and
RD152 deletions are also known to be characteristic of Beijing
genogroup strains which are prevalent worldwide, thought to be
highly virulent [7] and also associated with multi-drug resistance
[4,8]. Clinical presentations of tuberculosis have been shown to
differ depending on the infective M. tuberculosis strain group; Euro-
American strains are associated with increased lung consolidation,
while the meningitis caused by the East Asian/Beijing lineage was
associated with younger adults, more rapid disease progression
and fewer leucocytes in the cerebrospinal fluid (CSF) [9].
In vitro studies have shown that virulent M. tuberculosis Beijing
clinical isolates grow more rapidly than H37Rv in murine and
human macrophages as well as in THP-1 cell line model [8,10,11].
M. tuberculosis infection of macrophages has been shown to
induce both proinflammatory cytokines; Tumor necrosis factor
alpha (TNFa), Interleukin 2 (IL2) and Interleukin 6 (IL6) as well as
downregulatory cytokine; Interleukin 10 (IL10) [12]. TNFa is
essential for macrophage activation and granuloma formation
[13,14]. The release of TNFa in human macrophages infected
with M. tuberculosis has the dual effect of increasing anti-
mycobacterial activity by activating macrophages and inducing
granuloma formation, while excess TNFa results in host cell
necrosis and dissemination of mycobacteria [15]. TNFaalso
increases the expression of chemokine CCL2 (monocyte chemoat-
tractant protein (MCP-1)) by macrophages [16]. CCL2 plays a
role in granuloma formation [17] and is reported to contribute
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IL10 is important for regulating immunity in mycobacterial
infections and while IL10 is associated with progressive disease
[19], absence of IL10 results in lack of antimycobacterial
immunity [20].
Previous studies have shown that virulent clinical M. tuberculosis
strains grow faster and cause more necrosis than laboratory strain
H37Rv in murine bone marrow-derived macrophages [10].
Beijing genotype strains induce lower levels of proinflammatory
cytokines (TNFa, IL6, IL12) as compared with M. tuberculosis
H37Rv in human monocyte derived macrophages [11,21].
Overall, reduced pro-inflammatory responses have been associat-
ed with increased intracellular persistence of M. tuberculosis strains
[11,22,23].
It is known that RD1 encodes for highly antigenic proteins
thought to play an important role in immunomodulation of the
host by M. tuberculosis [24]. These and smaller deletions in M.
tuberculosis may contribute to adaptation of strains for improved
interactions with the host. These include a polymorphism in the
pks 15/1 gene which encodes for a phenol glycolipid whereby the
mutation in the glycolipid results in immunosuppression of host
responses. A previous study has shown that deletion of Rv1519 in
CH, an outbreak strain belonging to the CAS2 lineage resulted in
a higher secretion of immunosuppressive IL10 and IL6, contrib-
uting to its persistence in the human population [25].
This study explored the biological relevance of RD149 and of
concurrent RD149 and RD152 deletions on CAS1 strains. In vitro
broth growth of the CAS1 strains with RD149 and concurrent
RD149–152 deletions was compared with that of CAS1 strains
without deletions and with H37Rv. Intracellular growth of these
strains was investigated using the human acute monocytic
leukemia cell line (THP-1) [26,27,28]. Mycobacterium-induced
TNFa, IL6, CCL2 and IL10 secretion was also determined.
Materials and Methods
Ethics Statement
Approval for this study was taken from the Ethics Review
Committee of the Aga Khan University, Pakistan.
Mycobacterial strain selection
M. tuberculosis isolates used in this study were obtained from
diagnostic specimens submitted to the clinical laboratory at the
Aga Khan University and stored in the strain bank. All strains
were subcultured once on Middlebrook 7H10 agar before being
stored in aliquots in glycerol peptone broth (GPB) on beads at
270uC. Central Asian Strain1 (ST26) strains (n=133) from the
strain bank at the Aga Khan University previously screened for
RD deletions were included [5]. Of these 53 had RD149 deletions
alone and 25 strains showed concurrent RD149 and RD152
deletions [5]. From this latter pool, strains with RD149 (n=9) and
with concurrent RD149 and RD152 (n=9) were randomly
selected for this study along with 3 CAS1 strains without deletions
in RD149 or RD152 regions. Each strain culture was established
from a fresh aliquot of each stored strain. M. tuberculosis H37Rv
reference strain obtained from American Type Culture Collection
(ATCC) was used as a control.
Growth in broth
Growth in broth was assessed using radiometric methods; Study
strains were grown in 7H9 broth medium supplemented by 5%
ADC (Difco Laboratories, Detroit, MI, USA). The strains were
then inoculated onto Middlebrook 7H10 agar (Becton Dickinson,
Sparks, MD, USA) incubated for a 3 further weeks. Bacterial
colonies were suspended in 1 ml sterile PBS, vortexed vigorously
for 30 sec to obtain a single cell suspension and matched with 0.5
McFarland (approx cell density is 1.5610
8/ml).
The bacterial suspension was diluted (1:100) to a final
concentration of 1.5610
6/ml, 0.1 ml of the final concentration
was added to BACTEC 12B medium culture vials (Becton
Dickinson, USA) containing
14C-labelled fatty acid substrate and
incubated at 37uC for up to 37 days [29,30]. The growth in broth
for days 0 to 37 is mentioned in Figure S1. As peak growth was
observed at Day 2 for all strains measurements at this interval were
used for further analysis.
Intracellular growth
M. tuberculosis were first grown in Middlebrook 7H9 broth
medium supplemented by 5% ADC (Difco Laboratories, Detroit,
MI, USA) at 37uC to mid-logarithmic phase (OD620 nm=0?5).
Aliquots of mycobacteria at a stock concentration of 2610
6 CFU/
ml in 7H9 broth medium containing 15% glycerol were stored at
270uC for use in monocyte infection assays as described
previously [22].
The THP-1 monocyte cell line was obtained from the ATCC,
USA. THP-1 cells grown in RPMI 1640 (Gibco BRL) supple-
mented with 10% fetal calf serum, 10 mmol/L HEPES and
2 mmol/L glutamine at 37uCi n5 %C O 2 [31]. THP-1 cells were
plated at (2610
5 cells/ well) in 48 well tissue culture plates. The
cells were differentiated by addition of 20 ng/ml Phorbol Ester
Myristate (PMA, Sigma) and 5 ng/ml recombinant human
interferon gamma (rhIFNc, Endogen) for 24 hrs.
M. tuberculosis inoculum for infection was prepared as described
previously [31]. Briefly, THP-1 cells (2610
5/well) were infected
with M. tuberculosis (2610
5 CFU/ml) for 3 h (T
0), the supernatants
were collected and monolayers washed thoroughly with phosphate
buffer saline (PBS) to remove extracellular adherent mycobacteria.
For the T
0 wells, THP-1 cells were lysed with 100 ml of 0.5%
Triton X-100 and lysate plated on 7H10 agar plates for
enumeration by colony forming unit (CFUs) counts.
Fresh RPMI medium was added to the remaining wells until
harvested. Cell supernatants were collected at days 1 and 3 for
cytokine measurements, were filtered using 0.2 mm filters,
aliquoted and stored at 280uC until used. Cell lysates were plated
for CFUs at 1, 3, 5 and 7 days post-infection. The intracellular
growth pattern observed for each strain is depicted in Figure S2.
The largest change in growth was observed between days 0 and 3.
Therefore, analysis of intracellular growth for each strain was
calculated using the ratio of growth at day3/day 0 for each isolate.
Measurement of Cytokines and Chemokines
Cytokines (TNFa, IL6 and IL10) standards and monoclonal
antibody pairs for capture and detection obtained from Endogen
(Rockford, IL, USA) were used to obtain a dose response curve
with a range of detection from 3.9–1000 pg/ml using a sandwich
ELISA technique as described previously. Each well was measured
in duplicate. Chemokine, (CCL2) standards and monoclonal
antibody pairs for capture and detection obtained from R&D
Systems (Abingdon, UK) were used to obtain a dose response
curve with a range of detection from 6.25–1000 pg/ml for CCL2.
All measurements were carried out according to the manufactur-
er’s instructions and as reported previously [31,32].
Statistical analysis
Non–parametric statistical analysis was performed using the
Statistical Package for Social Sciences software (SPSS version
17.0). The analyzed variables for growth indices and CFU/ml
were compared using Mann-Whitney U Tests. While the
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way ANOVA (Tukey, Post Hoc analysis) and Kruskal Wallis
Test.
Results
M. tuberculosis strains were isolated from both male (n=9) as well
as female (n=12) patients, Table 1. The median ages of male
(24.5 y) and female (24 y) patients was comparable, p=0.36 as
analysed using the Mann-Whitney U Test.
CAS1 clinical strains show variable growth in broth
Growth of CAS1 strains with deletions was slower in broth
(RD149, p=0.024; and RD149-RD152, p=0.025) than that of
strains without deletions. Comparison of CAS1 strains with M.
tuberculosis H37Rv showed that while CAS1 strains without
deletion strains grew more rapidly in broth as compared with
M. tuberculosis H37Rv (p=0.036), growth of H37Rv was faster
than that of CAS1 strains with RD149 deletions (p=0.04),
Figure 1. When assessed individually however, the growth of
deletion strains showed variability; One strain with RD149;
and 3 strains with concurrent RD149-RD152 deletions grew
faster, whereas 6 strains with RD149 and 3 strains with RD149-
RD152 grew slower than the laboratory reference strain
H37Rv (Figure 2).
CAS1 strains with RD149 deletions show reduced
intracellular growth
Within THP-1 monocytes, CAS1 strains with RD149 deletion
strains showed reduced intracellular growth at day 3 post-infection
(p=0.013) in THP-1 cells as compared with CAS1 strains without
deletions, and also as compared to H37Rv (p=0.007), and CAS1
strains with concurrent RD149-RD152 deletion (p=0.029),
Figure 3.
Increased TNFa and IL10 induction in CAS1 deletion
strains
To investigate association between the presence of deletions and
the capacity of M. tuberculosis strains to elicit host cytokine
activation. TNFa, IL6, IL10 and CCL2 secretion by THP-1 cells
infected with CAS1 strains was measured. Significantly higher
levels of TNFa induction was noted by CAS1 strains; CAS1
without deletions (p=0.006), strains with RD149 (p=0.005) and
with concurrent RD149 and RD152 (p,0.001) as compared to M.
tuberculosis H37Rv. Within CAS1 strains though, isolates with
RD149 deletions induced significantly higher levels of TNFa as
compared to strains without deletions, (p=0.013), Figure 4A.
In comparison to M. tuberculosis H37Rv, CAS1 strains also
induced higher levels of IL10; CAS1 without deletions (p=0.005),
strains with RD149 (p=0.002) and strains with concurrent
RD149-RD152 deletions (p=0.001), Figure 4B.
Induction of IL6 and CCL2 by the study strains was
investigated. However, no differences were detected between IL6
induction by CAS1 strains and H37Rv, or between strains with
and without deletions; IL6 levels induced by the study strains were
Table 1. Characteristics of Mycobacterium tuberculosis CAS1
genotype strains used in the study.
No ID Age Gender Strain Source RD deletion
1 Reference H37Rv ATCC none
2 CAS1a 55 Male CAS1 (ST26) Sputum none
3 CAS1b 16 Female CAS1 (ST26) Sputum none
4 CAS1c 36 Female CAS1 (ST26) Sputum none
5 S1 23 Female CAS1 (ST26) Sputum RD149
6 S2 18 Female CAS1 (ST26) Sputum RD149
7 S5 70 Male CAS1 (ST26) Sputum RD149
8 S6 20 Female CAS1 (ST26) Sputum RD149
9 EP1 27 Male CAS1 (ST26) CSF RD149
10 EP2 5 Male CAS1 (ST26) CSF RD149
11 EP4 39 Female CAS1 (ST26) CSF RD149
12 EP7 29 Male CAS1 (ST26) Urine RD149
13 EP10 25 Female CAS1 (ST26) CSF RD149
14 S3 35 Female CAS1 (ST26) Sputum RD149-RD152
15 S4 20 Male CAS1 (ST26) Sputum RD149-RD152
16 S7 47 Female CAS1 (ST26) Sputum RD149-RD152
17 S8 20 Male CAS1 (ST26) Sputum RD149-RD152
18 S9 18 Female CAS1 (ST26) Sputum RD149-RD152
19 S10 22 Male CAS1 (ST26) Sputum RD149-RD152
20 EP6 17 Female CAS1 (ST26) CSF RD149-RD152
21 EP8 52 Female CAS1 (ST26) CSF RD149-RD152
22 EP9 60 Male CAS1 (ST26) CSF RD149-RD152
Central Asian Strain 1, CAS1 (ST26) as identified by SpolDB4.0.
Source of samples: Sputum, Cerebrospinal Fluid (CSF), Urine and American Type
Culture Collection.
‘None’ denotes strains which had no deletions in RD149 and RD152 regions.
doi:10.1371/journal.pone.0024178.t001
Figure 1. CAS1 strains with RD149 and concurrent RD149-
RD152 deletions show slower growth in broth as compared
with CAS1 (without deletions). The graph depicts the growth in
broth of M. tuberculosis strains H37Rv, CAS1 (without deletions, n=3),
CAS1 strains with RD149 (n=9) and concurrent RD149-RD152 (n=9)
deletions. Growth in broth was calculated as a ratio of growth at day 2/
day 0. The box and whiskers plot represent the data between 10
th and
90
th quartiles, with the horizontal line indicating the median value.
‘*’ denotes significantly reduced growth (p,0.05) as compared with
CAS1 (without deletions). ‘#’ denotes significantly reduced growth
(p,0.05) as compared with H37Rv using the Mann-Whitney U test. D
denotes deletions.
doi:10.1371/journal.pone.0024178.g001
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RD149 deletions; 526 pg/ml, CAS1 strains with concurrent
RD149 and RD152 deletions; 542 pg/ml and M. tuberculosis
H37Rv; 680 pg/ml. Similarly, CCL2 levels were comparable in
all the strains tested: CAS1 (without deletion); 1474 pg/ml, CAS1
with RD149 deletions; 1958 pg/ml, CAS1 with RD149 and
Figure 2. Differential growth of CAS1 strains with RD149 and concurrent RD149-RD152 deletions. The graph depicts the growth in
broth of CAS1 strains without deletions (CAS1, n=3), CAS1 with RD149 deletions (n=9) and CAS1 strains with concurrent RD149-RD152 deletions
(n=9) as compared with the laboratory strain M. tuberculosis H37Rv. The bar graph represents the median and 95% confidence interval (CI) of each
strain. ‘*’ denotes significantly reduced growth (p,0.05) as compared with H37Rv. ‘#’ denotes significantly increased growth (p,0.05) as compared
with H37Rv using the Mann-Whitney U test. D denotes deletions; ND denotes no deletions.
doi:10.1371/journal.pone.0024178.g002
Figure 3. CAS1 strains with RD149 deletions show reduced intracellular growth within THP-1 monocytes. THP-1 (2610
5 cells) were
infected with M. tuberculosis strains (2610
5 CFU/ml) and mycobacteria were quantitated at 0 and 3 days. Data is presented as the median of each
group as shown by a horizontal bar. ‘*’ denotes significantly reduced growth (p,0.05) as compared with M. tuberculosis H37Rv; CAS1 (without
deletions) and CAS1 with concurrent RD149-RD152 deletions using Mann-Whitney U test. D denotes deletions.
doi:10.1371/journal.pone.0024178.g003
RD149 Deletions Affect Growth and TNFa Induction
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e24178RD152 deletions; 2183.5 pg/ml and M. tuberculosis H37Rv;
1270 pg/ml.
Differential intracellular growth of strains from
pulmonary and extrapulmonary sources
To investigate whetherthesource; pulmonaryorextrapulmonary
had any bearing on strain virulence, growth and cytokine activation
in response to strains was compared. No difference was observed in
growth rates or activation of host cytokines between pulmonary or
extrapulmonary strains of CAS1 or CAS1 with concurrent RD149
and RD152 deletions. In contrast, extrapulmonary strains with
RD149 deletions showed increased intracellular growth (p=0.015)
and induced lower levels of TNFa (p=0.01), CCL2 (p=0.003) and
IL6 (p=0.008) secretion in THP-1 monocytes as compared with
strains from pulmonary sources, Table 2.
Discussion
This study showing that presence of RD149 deletions in M.
tuberculosis CAS1 strains is associated with reduced growth (in broth
and in vitro macrophages) and with increase in proinflammatory
TNFa suggests a role of RD149 in causing phenotypic diversity
within these strains.
Earlier studies on growth characteristics of M. tuberculosis strains
have hypothesized that faster growth of clinical strains such as
Beijing in comparison to the laboratory reference H37Rv may
contribute to their success in the establishment of disease [8].
Faster growth in broth seen amongst CAS1 strains without
deletions as compared with H37Rv in this study may thus be
contributing to the success of these strains. However, the presence
of RD149 either singly or concurrent with RD152 appears to
influence this advantage.
We found that the optimal time period to study intra-strain
growth differences was at 3 days post-stimulation. At this time
point, CAS1 strains with RD149 deletions showed reduced
intracellular growth in THP-1 macrophages as compared with
H37Rv, with CAS1 strains (without deletions) and with CAS1 with
concurrent RD149-RD152 deletions. This difference was not
present at the later 5 day time point. However, the intracellular
growth difference observed at the earlier time point is important as
it likely to represent early events in mycobacterium-host cell
interactions such as, uptake into the phagosome followed by
sorting within endosomal compartments of the host cell [33]. Early
events post uptake and entry into the macrophage are key to
determining phagosome biogenesis and outcome of the infection.
Therefore, variations between strains which affect intracellular
Figure 4. The CAS1 strains with RD149 and concurrent RD149-RD152 deletions induced increased TNFa secretion in THP-1
monocytes. THP-1 (2610
5 cells) were infected with M. tuberculosis strains (2610
5 CFU/ml) and cytokine levels in infected cell supernatants tested for
TNFa (18 h) and IL10 (72 h) post infection. ‘*’ (p,0.05) denotes significantly increased cytokine secretion as compared with M. tuberculosis H37Rv.
‘#’( p ,0.05) denotes significantly increased cytokine secretion as compared with CAS1 (without deletions) using Kruskal-Wallis test. A horizontal bar
indicates median values of each group. Graphs depict cytokines induced by H37Rv, CAS1 (without deletions), CAS1 with RD149 and concurrent
RD149-RD152 deletions. D denotes deletions. A, TNFaand B, IL10.
doi:10.1371/journal.pone.0024178.g004
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mycobacterial phagosome may well impact host immune response
and therefore the outcome of infection.
All CAS1 strains investigated induced higher TNFa as well
as IL10 levels in THP-1 cells than the laboratory strain H37Rv.
Our data is consistent with reports of increased TNFa and IL10
induction in THP-1 monocytes by clinical strains including the
Beijing genotype [8]. TNFa has been shown to play a crucial
role in macrophage activation and granuloma formation and
thus in controlling mycobacterial replication [34]. TNFa has
also been associated with cellular damage and dissolution of the
granuloma due to cellular necrosis [34]. While M. tuberculosis
infection of alveolar macrophages results in TNFa dependent
apoptosis [35] and pathogen killing, it may alternatively also
lead to the dissemination of the bacillus due to TNFa driven
necrosis [36]. It is therefore possible to hypothesize that
increased induction of the down modulatory IL10 together with
proinflammatory TNFa by CAS1 strains may thus contribute
to skewing the host immune response towards a down-
modulatory phenotype which would facilitate intra-macro-
phage growth of the strains.
CAS1 strains with RD149 deletions induced higher TNFa levels
as compared to CAS1 strains without deletions. Clinical isolate
CDC1551strainhavebeen shown toinduce higherTNFa responses
inmonocytes but to persistfor shorterperiods than themorevirulent
Beijingstrain[37].Similarly,avirulent Mycobacteriumsp.i sr e p o r t e dt o
induce higher TNFa secretion than the virulent strains [34].
Therefore, the reduced intracellular growth and increased TNFa
secretion of CAS1strains with RD149 deletions may besuggestive of
a decrease in virulence amongst the deletion strains.
Beijing strains have been shown to differ in their ability to
induce cytokines in both in vitro and in animal models [22,38].
Differences between Beijing strains have been attributed to
variation in the production of lipids including Phenolic glycolipids
(PGL); strains with mutations in the pks 15/1 gene induce higher
levels of cytokine-dependent Th1-type protective immune re-
sponses such as TNFa [7,39]. Recent studies have identified
variations in the transcriptome profiles of M. tuberculosis strains
from different lineages suggesting, that genetic variations may
impact phenotypic patterns of clinical strains [40]. It is likely
therefore that the differences observed in responses to CAS1
strains could be due to inter-strain variations perhaps even due to
the presence of RD deletions.
RD149 and RD152 are associated with mobile genetic elements
e.g., prophage and hot spots for IS6110 insertion, respectively
[41]. The Rv 1759c gene (wag22) within RD152 region is a
member of the PE family, polymorphic CG-repetitive sequences
(PGRS) subfamily of glycine rich proteins which are putative
virulence factors for M. tuberculosis [41]. The combined effect of
RD149 and RD152 deletions may differ from that of RD149
deletion strains due to difference in strain properties which result
from the variable antigenic profile of strains as a result of their
differing presentations. This may subsequently affect uptake and
intracellular growth of strains hence, the differential outcome of
infections with RD149 strains from that of strains with RD149-
RD152.
Within CAS1 strains with RD149 deletions, those from
extrapulmonary sites grew faster and induced lower levels of
TNFa, CCL2 and IL10 as compared with pulmonary strains. This
is consistent with trends from a previous study showing that
extrapulmonary M. tuberculosis strains grow faster and induce less
TNFa secretion in human monocyte derived macrophages [42].
To date, there is little data on the role of RD149 and RD152
deletions in either the virulence or the epidemiology of TB. The
current study comparing clinical strains with and without RD
deletions suggests that observed differences in growth and host
cytokine modulation are associated with deletions in RD149. We
hypothesize that the variations observed in the virulence patterns
of M. tuberculosis clinical isolates may be affected by the acquisition
of RD149 deletions and may further be dependent on the location
of the deletions on the bacterial chromosome. This is important
since the data suggests that these deletions may have an impact on
pathogenesis and therefore on clinical outcome of TB infection.
Supporting Information
Figure S1 Measurement of M. tuberculosis growth in
broth using the BACTEC system. M. tuberculosis H37Rv was
adjusted to approx cell density of 1.5610
6 bacterial cells/ml for
inoculation and subsequently grown for 37 days in the radiometric
BACTEC 460 TB system. To determine Colony Forming Units
(CFUs), bacterial suspension from 12B medium was plated on
7H10 agar medium and incubated for 3 weeks for enumeration.
Growth in broth was measured for H37Rv, CAS1 strains (without
deletions), CAS1 strains: S1, S2, S5, S6, EP1, EP2, EP4, EP7 and
EP10 with RD149 deletions and CAS1 strains: S3, S4, S7, S8, S9,
S10, EP6, EP8 and EP9 with concurrent RD149-RD152 deletions
Table 2. Comparison of growth characteristics and cytokine activation of CAS1 strains from pulmonary and extrapulmonary
sources with RD149 and concurrent RD149-RD152 deletions.
Strains with RD149 deletions
Strains with concurrent RD149-RD152
deletions
Groups Pul(n=4) Epul(n=5) Pvalue Pul(n=6) Epul(n=3) Pvalue
Growth in broth
## 1.56 1.1 0.373 1.82 1.26 0.201
Growth in THP-1 cells
— || 1.31 1.58 0.015
* 1.6 1.597 0.19
TNFa (pg/ml) 4153 3164 0.01
* 3092 3008 0.767
CCL2 (pg/ml) 2489.5 1306 0.003
* 2250 1392 0.153
IL6 (pg/ml) 620.5 314 0.008
* 663.5 450 0.051
IL10 (pg/ml) 10.82 14.33 0.643 18.1 36 1.00
CAS1: Central Asian Strain 1 (ST26); Pul (pulmonary source); EPul (extrapulmonary source).
*denotes a significant difference between strains with deletions when compared between median values of Pul and EPul, p,0.05 using Mann-Whitney U test.
##denotes a growth ratio of strain calculated as growth at day 2/ initial growth at day 0.
— ||denotes intracellular growth calculated as CFU/ml at day 3/CFU/ml at day 0.
doi:10.1371/journal.pone.0024178.t002
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of two independent experiments with ‘y’ error bars indicating
standard deviation is illustrated in Figure S1. All experiments were
repeated twice (with duplicates in each experiment). The data
presented is the mean of 2 experiments.
(TIF)
Figure S2 Intracellular growth of M. tuberculosis
growth in THP-1 monocytes. The THP-1 cells (2610
5
cells/well) were infected with M. tuberculosis H37Rv at
(2610
5 CFU/ml) and cultured for upto 7 days. Graph depicts
mycobacterial numbers harvested from cells upon lysis of infected
monolayers at 0, 1, 3 and 5 days post infection. The intracellular
growth (log10) was measured for H37Rv, CAS1 strains (without
deletions), CAS1 strains: S1, S2, S5, S6, EP1, EP2, EP4, EP7 and
EP10 with RD149 deletions and CAS1 strains: S3, S4, S7, S8, S9,
S10, EP6, EP8 and EP9 with concurrent RD149-RD152 deletions
at days 0, 1, 3 and 5. Data shown is the mean of three independent
experiments with ‘y’ error bars indicating standard deviation is
illustrated in Figure S2. All experiments were performed in
triplicate and the data presented is the mean of 3 experiments.
(TIF)
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